E.-E. N. Vlachou, G. S. Armatas, and K. E. Litinas
Vol 000
117.1, 128.2, 143.4, 153.3, 159.1, 161.2; MS (ESI): m/z
208 [M + H]+., 206 [M-H]À. Anal. Calcd for C9H5NO5:
C, 52.19; H, 2.43; N, 6.76. Found: C, 52.11; H, 2.49; N,
Method B; 16 mg, 25% yield, Method C), light yellow
solid, mp 191–193°C (MeOH) (lit. [12] mp 189–190°C).
6.68.
9-Methyl-2-phenyl-7H-chromeno[5,6-d][1,3]oxazol-7-one
(3b). [55% yield (Method A), 49% yield (Method B),
REFERENCES AND NOTES
and 33% yield (Method C)] light yellow solid, mp
208–210°C (MeOH) (lit. [14] mp 211–212°C).
2-Phenyl-6H-chromeno[6,7-d][1,3]oxazol-6-one (6a). (19 mg,
30% yield, Method A; 25 mg, 40% yield, Method B;
[1] Murray, D. H.; Mendez, J.; Brown, S. A. In The Natural
Coumarins: Occurrence, Chemistry and Biochemistry; John Wiley &
Sons: New York, 1982; p 1.
[2] O’Kennedy, R.; Thornes, R. D. Coumarins: Biology, Applica-
tions and Mode of Action; John Wiley & Sons: Chichester, 1997; p 1.
[3] Fylaktakidou, K. C.; Hadjipavlou-Litina, D. J.; Litinas, K. E.;
Nicolaides, D. N. Curr Pharm Des 2004, 10, 3813.
[4] Borges, F.; Roleira, F.; Milhazes, N.; Santana, L.; Uriarte, E.
Curr Med Chem 2005, 12, 887.
[5] Kostova, I.; Raleva, S.; Genova, P.; Argirova, R. Bioinorg
16.5 mg, 26% yield, Method C), yellow solid, mp 207–
209°C (MeOH), IR (KBr): 3053, 1720, 1610, 1575 cmÀ1
;
1H–NMR (CDCl3, 300 MHz) δ 6.43 (d, 1H, J = 9.6 Hz),
7.54 (s, 1H), 7.55–7.57 (m, 3H), 7.82 (s, 1H), 7.83 (d,
1H, J = 9.6 Hz), 8.25 (dd, 2H, J1 = 1.9 Hz, J2 = 7.6 Hz);
13C–NMR (CDCl3, 75 MHz) δ 99.5, 115.3, 116.5,
118.1, 126.3, 127.8, 129.1, 132.3, 139.2, 143.9, 152.3,
152.6, 160.5, 164.8; MS (ESI): m/z 264 [M + H]+., 302
[M + K]+, 318 [M + Na + MeOH]+ Anal. Calcd for
C16H9NO3: C, 73.00; H, 3.45; N, 5.32. Found: C, 73.07;
H, 3.53; N, 5.39.
[6] Dall’Acqua, F.; Vedaldi, D. In CRC Handbook of Organic
Photochemistry and Photobiology; Horspool, W. M.; Song, P. S. Eds.;
CRC Press: Boca Raton, FL, 1995; pp 1341–1350.
[7] Kitamura, N.; Kohtani, S.; Nakagaki, R.
Photobiol C Photchem Rev 2005, 6, 168.
J Photochem
[8] Pathak, M. A.; Fellman, J. H.; Kaufman, K. D. J Invest
Dermatol 1960, 35, 165.
[9] Sahoo, S. S.; Shukla, S.; Nandy, S.; Sahoo, H. B. Eur J Exp
Biol 2012, 2, 899.
[10] Kontogiorgis, C.; Hadjipavlou-Litina, D. J. Enz Inh Med
Chem 2003, 18, 63.
[11] Prasanna, B.; Sandeep, A.; Revathi, T. World J Pharm Pharm
Sci 2014, 3, 404.
6-(Benzylamino)-7-hydroxy-2H-chromen-2-one (7). (3 mg,
5% yield, Method C), light yellow solid, mp 180–182°C
(MeOH), IR (KBr): 3424, 3212, 3057, 2924, 2848, 1724,
1
1606, 1562 cmÀ1; H–NMR (CDCl3, 300 MHz) δ 5.04
[12] Colotta, V.; Catarzi, D.; Varano, F.; Cecchi, L.; Filacchioni,
G.; Martini, C.; Giusti, L.; Lucacchini, A. Il Farmaco 1998, 53, 375.
[13] Kaufman, K. D.; McBride, D. W.; Eaton, D. C. J Org Chem
1965, 30, 4344.
[14] Reddy, S. J Indian Chem Soc 1981, 58, 599.
[15] Bezergiannidou-Balouctsi, C.; Litinas, K. E.; Malamidou-
Xenikaki, E.; Nicolaides, D. N.; Mentzafos, D.; Terzis, A. Tetrahedron
1993, 49, 9127.
(s, 2H), 6.37 (d, 1H, J = 9.6 Hz), 6.79 (s, 1H), 7.36–738
(m, 6H), 7.60 (d, 1H, J = 9.6 Hz); 13C–NMR (CDCl3,
75 MHz) δ 46.5, 112.5, 115.4, 115.7, 117.6, 127.9,
129.2, 132.3, 140.9, 143.0, 143.7, 155.9, 160.2, 161.6;
MS (ESI): m/z 268 [M
C16H13NO3: C, 71.90; H, 4.90; N, 5.42. Found: C, 71.85;
+
H]+ Anal. Calcd for
H, 4.79; N, 5.34.
8-Methyl-2-phenyl-6H-chromeno[6,7-d][1,3]oxazol-6-one
(6b). [71% yield (Method A), 57% yield (Method B)
and 25% yield (Method C)] light yellow solid, mp
231–232 °C (MeOH) (lit. [30] mp 232–233°C).
2-Phenyl-8H-chromeno[8,7-d][1,3]oxazol-8-one (9a). (28 mg,
45% yield, Method A; 30 mg, 48% yield, Method B;
[16] Abdelghani, S.; Abd El-Aal, A.; Shehab, W.; El-Mobayed, M.
Synthesis 2003 1373.
[17] Saha, P.; Ramana, T.; Purkait, N.; Ali, M. A.; Paul, R.;
Punniyamurthy, T. J Org Chem 2009, 74, 8719.
[18] Bonnamour, J.; Bolm, C. Org Lett 2008, 10, 2665.
[19] Peng, J.; Zong, C.; Ye, M.; Chen, T.; Gao, D.; Wang, Y.;
Chen, C. Org Biomol Chem 2011, 9, 1225.
[20] Sejas, J.; Vazquez-Tato, M.; Carballido-Reboredo, M.;
Crecente-Campo, J.; Romar-Lopez, L. Synlett 2007, 313.
[21] Chen, F.; Shen, C.; Yang, D. Tetrahedron Lett 2011, 52, 2128.
[22] Blacker, A. J.; Farah, M. M.; Hall, M. I.; Mrsden, S. P.; Saidi,
O.; Williams, J. M. J. Org Lett 2009, 11, 2039.
[23] Maleki, B.; Baghayeri, M.; Vahdat, S. M.; Mohammadzadeh,
A.; Akhoondi, S. RSC Adv 2015, 5, 46545.
[24] Wu, M.; Hu, X.; Liu, J.; Liao, Y.; Deng, G.-J. Org Lett 2012,
14, 2722.
[25] Tang, L.; Guo, X.; Yang, Y.; Zha, Z.; Wang, Z. Chem
Commun 2014, 50, 6145.
[26] Symeonidis, T. S.; Lykakis, I. N.; Litinas, K. E. Tetrahedron
2013, 69, 4612.
[27] Symeonidis, T. S.; Hadjipavlou-Litina, D. J.; Litinas, K. E.
J Heterocyclic Chem 2014, 51, 642.
22 mg, 36% yield, Method C), light yellow solid, mp 197–
199°C (MeOH), IR (KBr): 3071, 1729, 1657 cmÀ1; H–
1
NMR (CDCl3, 300 MHz) δ 6.45 (d, 1H, J = 9.6 Hz), 7.49
(d, 1H, J = 8.5 Hz), 7.54–7.58 (m, 3H), 7.82 (d, 1H,
J = 8.5 Hz), 7.86 (d, 1H, J = 9.6 Hz), 8.29 (dd, 2H,
J1 = 1.7 Hz, J2 = 7.6 Hz); 13C–NMR (CDCl3, 75 MHz) δ
99.5, 107.4, 115.4, 118.1, 126.6, 128.1, 129.1, 132.2, 139.2,
139.7, 143.9, 150.8, 160.5, 164.6; MS (ESI): m/z 264
[M
+
H]+., 296 [M
+
H
+
MeOH]+., 318
[M + Na + MeOH]+ Anal. Calcd for C16H9NO3: C, 73.00;
H, 3.45; N, 5.32. Found: C, 72.87; H, 3.51; N, 5.22.
6-Methyl-2-phenyl-8H-chromeno[8,7-d][1,3]oxazol-8-one
(9b). [38% yield (Method A), 60% yield (Method B),
and 31% yield (Method C)] light yellow solid, mp
232–234°C (MeOH) (lit. [11] mp 232–234°C).
2-Phenyl-4H-chromeno[3,4-d][1,3]oxazol-4-one (11).
(20.5 mg, 33% yield, Method A; 16 mg, 25% yield,
[28] Lei, L.; Yang, D.; Liu, Z.; Wu, L. Synth Commun 2004, 34,
985.
[29] Lin, S.-T.; Yang, F.-M.; Yang, H.-J.; Huang, K.-F. J Chem
Research (S) 1995, 372.
[30] Cires, L.; Ofenberg, H.; Craita, C. Org Prep Proc Int 2001, 33,
361.
[31] Iaroshenko, V. O.; Mkrtchyan, S.; Gevorgyan, A.; Vilches-
Herrera, M.; Sevenand, D. V.; Villinger, A.; Ghochikyan, T. V.;
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet